🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Tanya E. Keenan

Merck & Co., Inc., Rahway, NJ, USA (United States)

ORCID: 0000-0001-5300-9998
MedicineBiochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

2in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Data from Clinical Efficacy and Molecular Response Correlates of the WEE1 Inhibitor Adavosertib Combined with Cisplatin in Patients with Metastatic Triple-Negative Breast Cancer

(2023)10.1158/1078-0432.c.6530060.v1
Top 100%
0DataRank
Top 100%0 citations

Tianyu Li, Tuulia Vallius, Jennifer L. Guerriero, Nabihah Tayob, Bose Kochupurakkal +17 more

Papers

Driven by 11 papers — median percentile 0. Top paper: “Molecular correlates of response to eribulin and pembrolizumab in hormone receptor-positive metastatic breast cancer”.

Molecular correlates of response to eribulin and pembrolizumab in hormone receptor-positive metastatic breast cancer

Nature Communications(2021)10.1038/s41467-021-25769-z
N/A
1.8DataRank · unranked
48 citations

Jennifer L. Guerriero, Romualdo Barroso‐Sousa, Tianyu Li, Tess A. O’Meara, Anita Giobbie‐Hurder +24 more

Phase Ib study of pembrolizumab in combination with trastuzumab emtansine for metastatic HER2-positive breast cancer

Journal for ImmunoTherapy of Cancer(2022)10.1136/jitc-2022-005119
N/A
1.2DataRank · unranked
39 citations

Tanya E. Keenan, Tianyu Li, Nabihah Tayob, Gerburg M. Wulf, Edward T. Richardson +10 more

Clinical Efficacy and Molecular Response Correlates of the WEE1 Inhibitor Adavosertib Combined with Cisplatin in Patients with Metastatic Triple-Negative Breast Cancer

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-3089
N/A
0.596DataRank · unranked
52 citations

Tianyu Li, Tuulia Vallius, Jennifer L. Guerriero, Nabihah Tayob, Bose Kochupurakkal +17 more

Integrating molecular profiles into clinical frameworks through the Molecular Oncology Almanac to prospectively guide precision oncology

Nature Cancer(2021)10.1038/s43018-021-00243-3
N/A
0.574DataRank · unranked
45 citations

Nathanael D. Moore, Nicholas Moore, Eric Kofman, Saud H. AlDubayan, Alexander T. M. Cheung +14 more

Nivolumab in combination with cabozantinib for metastatic triple-negative breast cancer: a phase II and biomarker study

npj Breast Cancer(2021)10.1038/s41523-021-00287-9
N/A
0DataRank · unranked
51 citations

Tanya E. Keenan, Tianyu Li, Nabihah Tayob, Lorenzo Trippa, Ricardo Pastorello +11 more

Clinical interpretation of integrative molecular profiles to guide precision cancer medicine

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.09.22.308833
N/A
0DataRank · unranked
0 citations

Nathaniel D Moore, Nicholas Moore, Eric Kofman, Saud H. AlDubayan, Alexander T. M. Cheung +14 more

Germline variants associated with immunotherapy-related adverse events

medRxiv(2022)10.1101/2022.04.10.22273627
N/A
0DataRank · unranked
0 citations

Sarah Abou Alaiwi, Wenxin Xu, Vivek Naranbhai, Amin H. Nassar, Ziad Bakouny +26 more

Data from Clinical Efficacy and Molecular Response Correlates of the WEE1 Inhibitor Adavosertib Combined with Cisplatin in Patients with Metastatic Triple-Negative Breast Cancer

(2023)10.1158/1078-0432.c.6530060.v1
Top 100%
0DataRank
Top 100%0 citations

Tianyu Li, Tuulia Vallius, Jennifer L. Guerriero, Nabihah Tayob, Bose Kochupurakkal +17 more

Data from Clinical Efficacy and Molecular Response Correlates of the WEE1 Inhibitor Adavosertib Combined with Cisplatin in Patients with Metastatic Triple-Negative Breast Cancer

(2023)10.1158/1078-0432.c.6530060
Top 100%
0DataRank
Top 100%0 citations

Tianyu Li, Tuulia Vallius, Jennifer L. Guerriero, Nabihah Tayob, Bose Kochupurakkal +17 more

896 Characterizing macrophage heterogeneity in HR+/HER2- metastatic breast cancer reveals novel mechanisms of resistance

Regular and Young Investigator Award Abstracts(2023)10.1136/jitc-2023-sitc2023.0896
N/A
0DataRank · unranked
0 citations

Kenichi Shimada, Madeline G Townsend, Tianyu Li, Nabihah Tayob, Molly DiLullo +9 more

Cellular reprogramming during anti-PD-1 and chemotherapy treatment in early-stage primary hormone receptor-positive breast cancer

Nature Communications(2025)10.1038/s41467-025-66659-y
N/A
0DataRank · unranked
2 citations

Adrienne G. Waks, Erica Pimenta, Breanna Titchen, Kevin Bi, Sabrina Y. Camp +16 more